Free public records show Mirum Pharmaceuticals, Inc. in 3 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Mirum Pharmaceuticals, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
12 active studies led by Mirum Pharmaceuticals, Inc., of 40 in all
Source: ClinicalTrials.gov, Studies with Mirum Pharmaceuticals, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
5 approvals with a product on the US market
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
Annual reports and other filings with the US Securities and Exchange Commission.
Source: SEC EDGAR, Company filings, CIK 1759425.
Studies Mirum Pharmaceuticals, Inc. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Mirum Pharmaceuticals, Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Mirum Pharmaceuticals, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Mirum Pharmaceuticals, Inc. is in.
Stories on the topics Mirum Pharmaceuticals, Inc. works in.
Behind every insurance claim is a standard electronic message. The CAQH Index says $20 billion a year could…
Read
Skin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Read
TB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade…
ReadSearch all reports for Mirum Pharmaceuticals, Inc. All companies